Dr. Lindsay Parker

Research Outputs

Peer Reviewed Journal Articles

Journal Impact Factors (JIF) and journal quartile (Q) were obtained from Journal Citation Reports (ISI Web of Knowledge). Quartile ranking indicates the impact of the journal in its discipline (e.g. Q1 = the top 25 % of journals in that subject category). Number of citations were obtained from Google Scholar. *authors have contributed equally.

Career total = 25

2019=2          2018=4            2017=3             2016=4             2015=5             2014=0           2013=3          2012=1            2011=0             2010=1             2009=0             2008=1             2007=1

  1. Garcia-Bennett AE, Dass AE, Moroni I, Rastogi ID, Parker LM, Packer NH, Brown LJ (2019) Influence of surface chemistry on the formation of the protein corona on Nanodiamonds (April 15 In Press, Journal of Materials Chemistry B) JIF: 4.776 Q1 (Materials Science)
  2. Parker LM, Sayyadi N, Staikopoulos V, Shrestha A, Hutchinson MR, Packer NH (2019). Visualizing neuroinflammation with fluorescence and luminescent lanthanide based in situ hybridization. https://doi.org/10.1186/s12974-019-1451-2 (March 8 In Press Journal of Neuroinflammation). JIF: 5.193 Q1 (Neurosciences)
  3. Iqbal S, Ghanimi Fard M, Everest-Dass A, Packer NH, Parker LM (2018). Understanding cellular glycan surfaces in the central nervous system. doi:10.1042/BST20180330 (In Press, Biochemical Society Tranactions). JIF: 3.394 Q2 (Biochemistry and Molecular Biology)
  4. Shathili AM, Brown HM, Everest-Dass AV, Tan TCY, Parker LM, Thompson JG, Packer NH (2018). The effect of streptozotocin-induced hyperglycemia on N-and O-linked protein glycosylation in mouse ovary. Glycobiology https://doi.org/10.1093/glycob/cwy075. JIF: 3.664 Q2 (Biochemistry and Molecular Biology) Citations: 1
  5. Gissibl A, Care A, Parker LM, Iqbal S, Hobba G, Nevalainen, Sunna A (2018). Microwave pretreatment of paramylon enhances the enzymatic production of soluble β 1,3-glucans with immunostimulatory activity. Carbohydrate Polymers. 2018, 196:339-347. doi: 10.1016/j.carbpol.2018.05.038. JIF: 5.158 Q1 (Applied Chemistry)
  6. Cordina NM, Sayyadi N, Parker LM, Zhao Z, Everest-Dass A, Stoodley M, Brown L, Packer NH (2018). Reduced background autofluorescence for cell imaging using nanodiamonds and lanthanide chelates. Scientific Reports. 2018 Mar 14;8(1):4521. doi: 10.1038/s41598-018-22702-1. JIF: 4.122 Q1 (Multidisciplinary Sciences) Citations: 1
  7. Wearne TA, Parker LM, Franklin JL, Goodchild AK, Cornish JL (2017). Methamphetamine-induced behavioural sensitization induces specific interneuronal mRNA pathology across the prelimbic and orbitofrontal cortices. Progress in Neuropsychopharmacology & Biological Psychiatry. Jul 3;77:42-48. doi: 10.1016/j.pnpbp.2017.03.018 JIF: 4.185 Q1 (Neurosciences)
  8. Alikhani M, Mirzaei M, Sabbaghian M, Parsamatin P, Karamzadeh R, Adib S, Sodeifi N, Gilani MAS, Zabet-Moghaddam M, Parker LM, Wo Y, Haynes PA, Gourabi H, Baharvand H, and Salekdeh GH (2017). Quantitative proteomic analysis of human testis reveals system-wide molecular and cellular pathways associated with non-obstructive azoospermia. Journal of Proteomics Jun 6;162:141-154. doi: 10.1016/j.jprot.2017.02.007 JIF: 3.722 Q1 (Biochemical Research Methods) Citations: 2
  9. Parker LM, Le S, Wearne T, Hardwick K, Kumar NN, Robinson KJ, McMullan S, Goodchild AK (2017). Neurochemistry of neurons in the ventrolateral medulla activated by hypotension: Are the same neurons activated by glucoprivation? Journal of Comparative Neurology Jun 15;525(9):2249-2264. doi: 10.1002/cne.24203. JIF: 3.400 Q2 (Neurosciences) Citations: 2
  10. Wearne TA, Parker LM, Franklin JL, Goodchild AK, Cornish JL (2016). GABAergic mRNA expression is differentially expressed across the prelimbic and orbitofrontal cortices of rats sensitized to methamphetamine: Relevance to psychosis. Neuropharmacology, 111, 107-118 doi:10.1016/j.neuropharm.2016.08.038 JIF: 4.249 Q1 (Neurosciences) Citations: 5
  11. Reineck P, Francis A, Orth A, Lau DWM, Nixon-Luke RDV, Rastogi ID, Razali WAW, Cordina NM, Parker LM, Sreenivasan VKA, Brown LJ, Gibson BC (2016). Brightness and Photostability of Emerging Red and Near-IR Fluorescent Nanomaterials for Bioimaging. Advanced Optical Materials. 4(10): p. 1549-1557 doi:10.1002/adom.201600212 JIF: 7.430 Q1 (Materials Science, Multidisciplinary) Citations: 24
  12. Jacobsen JHW, Parker LM, Staikopoulos V, Schartner E, Tsiminis G, Hutchinson MR, Mustafa S (2016). Novel imaging tools for investigating the role of immune signaling in the brain. Brain Behavior and Immunity. 58: 40-47. doi:10.1016/j.bbi.2016.04.014 JIF: 6.306 Q1 (Neurosciences) Citations: 4
  13. Wearne TA, Parker LM, Franklin JL, Goodchild AK, Cornish JL (2016). GABAergic mRNA expression is upregulated in the prefrontal cortex of rats sensitized to methamphetamine. Behavioural Brain Research. 297:224-30. doi: 10.1016/j.bbr.2015.10.026 JIF: 3.173 Q2 (Neurosciences) Citations: 9
  14. Taleahmad S, Mirzaei M, Parker LM, Hassani SN, Mollamohammadi S, Sharifi-Zarchi A, Haynes PA, Baharvand H, Salekdeh G (2015). Proteome Analysis of Ground State Pluripotency. Scientific Reports. 5:17985. doi: 10.1038/srep17985 JIF: 4.122 Q1 (Multidisciplinary Sciences) Citations: 17
  15. Baracz SJ, Parker LM, Suraev AS, Everett NA, Goodchild AK, McGregor IS, Cornish JL (2015). Chronic methamphetamine self-administration dysregulates oxytocin plasma levels and oxytocin receptor fibre density in the nucleus accumbens core and subthalamic nucleus of the rat. Journal of Neuroendocrinology. 28(4) doi: 10.1111/jne.12337 JIF: 3.392 Q2 (Neurosciences) Citations: 15
  16. Le S, Turner AJ, Parker LM, Burke PG, Kumar NN, Goodchild AK, McMullan S (2015). Somatostatin 2A Receptors are not expressed on functionally identified respiratory neurons in the ventral respiratory column of the rat. Journal of Comparative Neurology. 524(7): p. 1384-98. doi: 10.1002/cne.23912 (JIF: 3.400 Q2 (Neurosciences) Citations: 4
  17. Vakilian H, Mirzaei M, Tabar MS, Pooyan P, Rezaee LH, Parker LM, Haynes PA, Gourabi H, H Baharvand, and Salekdeh GH (2015). DDX3Y, a Male Specific Region of Y Chromosome Gene, may modulate neuronal differentiation. Journal of Proteome Research. 14(9), pp 3474–3483. JIF: 3.950 Q1 (Biochemical Research Methods) Citations: 10
  18. *Parker LM, *Damanhuri H, Fletcher S, McMullen S, Goodchild AK (2015). Hydralazine administration activates sympathetic preganglionic neurons whose activity mobilizes glucose and increases cardiovascular function. Brain Research. 1604:25-34. JIF: 3.125 Q3 (Neurosciences) Citations: 1
  19. Parker LM, Kumar NK, Lonergan T, McMullen S, Goodchild AK (2013). Distribution and neurochemical characterization of neurons in the rat ventrolateral medulla activated by glucoprivation. Brain Structure and Function. 220(1):117-34. doi: 10.1007/s00429-013-0642-3 JIF: 4.231 Q1 (Neurosciences) Citations: 11
  20. Parker LM, Kumar NK, Lonergan T, Goodchild AK (2013). Neurochemical codes of sympathetic preganglionic neurons activated by glucoprivation. Journal of Comparative Neurology. 521(12):2703-18 JIF: 3.400 Q2 (Neurosciences) Citations: 15
  21. Wehrwein EA, Novotny M, Swain GM, Parker LM, Esfahanian M, Spitsbergen JM, Habecker BA, and Kreulen DL (2013). Regional changes in cardiac and stellate ganglion norepinephrine transporter in DOCA-salt hypertension. Autonomic Neuroscience: Basic and Clinical. 179(1-2):99-107 JIF: 2.605 Q4 (Neurosciences) Citations: 6
  22. *Parker LM, *Tallapragada VJ, Kumar NN, Goodchild AK (2012). Distribution and localization of Gα proteins in the rostral ventrolateral medulla of normotensive and hypertensive rats: focus on catecholaminergic neurons. Neuroscience 218:20-34 JIF: 3.382 Q2 (Neurosciences) Citations: 5
  23. Kumar NN, Allen K, Parker LM, Damanhuri H, Goodchild AK (2010). Neuropeptide coding of sympathetic preganglionic neurons; focus on adrenally projecting populations. Neuroscience. 170(3), 789-99 JIF: 3.382 Q2 (Neurosciences) Citations: 17
  24. Wehrwein EA, Parker LM, Wright AA, Spitsbergen JM, Quaiserova-Mocko V, Novotny M, Swain GM, Kreulen DL (2008). Cardiac Norepinephrine Transporter protein is regionally expressed across heart chambers and is inversely correlated to chamber norepinephrine content. American Journal of Physiology- Regulatory, Integrative and Comparative Physiology. 295(3), pp. R857-R863 JIF: 3.082 Q2 (Physiology) Citations: 22
  25. Cao X, Dai X, Parker LM, Kreulen DL (2007). Differential Regulation of NADPH Oxidase in Sympathetic and Sensory Ganglia in Deoxycorticosterone Acetate Salt Hypertension. Hypertension. 50(4), pp. 663-671 JIF: 6.823 Q1 (Peripheral Vascular Disease) Citations: 24

Invited/Contributed Talks

Invited Talks:

  1. Utilising glycobiology for fluorescent nanodiamond uptake and imaging in the central nervous system. 2019 Photonics & Electromagnetics Research Symposium (PIERS) Rome, Italy June 17-20. 2019
  2. Utilising glycan biology for nanoparticle based uptake and imaging. Institute for Glycomics Weekly Seminar Series, 3 Aug 2018, Griffith University, Gold Coast, Australia .2018
  3. Utilising glycan biology for nanoparticle based uptake and imaging. Queensland Brain Institute Single Molecule Imaging Group Presentation (invited by Prof Fred Meunier), 1 Aug 2018, University of Queensland, Brisbane, Australia. 2018
  4. Applications for nanodiamonds in bio-imaging. Australian Diamond Pathfinder Meeting, 26 July 2018, RMIT University, Melbourne, Australia. 2018
  5. Utilising glycan biology for nanoparticle based uptake and imaging. Ingham Institute’s Weekly Research Presentation Series, 26 June 2018, Ingham Institute for Applied Medical Research, Liverpool Hospital, Australia. 2018
  6. Targeting the cellular glycan surface for nanoparticle based uptake and imaging (plenary). MBSANZ NSW Branch Scientific Meeting for “The Extracellular Matrix in Health and Disease”, 11 May 2018, Centenary Institute, University of Sydney, Australia. 2018
  7. Understanding the cellular glycan surface for central nervous system targeting and imaging. Hunter Cell Biology Meeting Australia, March 19-22, Hunter Valley, Australia. 2018
  8. Understanding the cellular glycan surface for central nervous system nanoparticle based targeting and imaging. International Women’s Day Featured Department Seminar, 7 March 2018, Macquarie University, Australia. 2018
  9. From nanoscience to neuroscience: novel probes for background-free neuroimaging. 8th Australian Neurotrauma Symposium, 16-17 Oct, The Wicking Dementia Research and Education Centre Faculty of Health, University of Tasmania, Australia. 2017
  10. Novel bioprobes for background-free neuroimaging and cellular tracing. Jilin University-Macquarie University Matchmaking Workshop on Novel Optical Functional Materials and Their Applications Towards Biophotonics, 13 Sept 2017, State Key Lab for Supramolecular Structure and Materials, Jilin University, China. 2017
  11. Novel bioprobes for background-free neuroimaging and cellular tracing. Mini-symposium on Lanthanide Bioapplications, 11 Sept 2017, Department of Chemistry, Dalian University of Technology, China. 2017
  12. Novel bioprobes for background-free neuroimaging and cellular tracing. Neuroscience and Non-communicable Diseases Weekly Seminar Series, 11 Aug 2017, School of Medical Science, University of New South Wales, Australia. 2017
  13. Biosensors and glycoproteins: linking nanoscience to neuroscience. Nanotechnology focused Biosensor Symposium, 30 Nov 2016, School of Biomedical Sciences, University of Melbourne. 2016
  14. New tools for measuring mRNA levels in cells and spinal cord tissues. 11 Feb 2016 at the University of Colorado Boulder Neuroscience Department (Guest of Prof Stephen Maier). 2016

Contributed Talks:

  1. Wehrwein EA, Parker LM, Esfahanian M, Kreulen DL. “Stellate Ganglionic Norepinephrine Transporter in Hypertension”. FASEB (Neural Mechanisms in Cardiovascular Regulation) Conference, Sydney, Australia, July 2007.
  2. Parker LM, Esfahanian M, Wehrwein EA, Cao X, Affonso CL, Wang X, Kreulen DL. “Endothelin B Receptors in Sympathetic Ganglia of Rescued ETB Deficient Rats”. Regional Hypertension Conference, Gull Lake, MI, September 2007.
  3. Parker LM “Phospholipase C β in the Rostral Ventrolateral Medulla”. ASAM data club, Sydney, Australia, September 2008.
  4. Parker LM. “Endothelin-1 and Cardiovascular Disease”. ASAM data club, Sydney, Australia, October 2008
  5. Parker LM. “In Situ PCR-amplification and detection of mRNA and DNA sequences”ASAM data club, Sydney, Australia, February 2009.
  6. Parker LM. “Localization of Phospholipase C Beta in Cardiovascular Neurons” Departmental commencement program ASAM, Sydney, Australia, March 2009.
  7. Parker LM. “Gα Subunit mRNA in Brainstem”ASAM data club, Sydney, Australia, April 2009.
  8. Parker LM. “Building a cDNA Library”. ASAM data club, Sydney, Australia, July 2009.
  9. Parker LM. “Distribution of Enkephalin and PACAP in Dorsal Root Ganglia Neurons Which Project to the Adrenal Medulla”. ASAM data club, Sydney, Australia, September 2009.
  10. Parker LM. “Gα Subunit Isoform Distribution in Cardiovascular Brain Areas”ASAM data club, Sydney, Australia, November 2009.
  11. Parker LM. “Gα Subunit Distribution in Cardiovascular Areas” Higher degree research showcase, Macquarie University, Sydney, Australia, December 2009.
  12. Parker LM. “PLCβ Isoform mRNA Distribution in the Rat Adrenal Gland”ASAM data club, Sydney, Australia, August 2010.
  13. Parker LM. “Chemical Coding of Sympathoadrenal Neurons”. Higher degree research showcase, Macquarie University, Sydney, Australia, November 2010.
  14. Parker LM. “Activation of Sympathoadrenal Pathway After Glucoprivation”ASAM data club, Sydney, Australia, May 2011.
  15. Parker LM. “Adrenaline and Glucagon- Partners in Giving You Energy”. ASAM data club, Sydney, Australia, August 2011.
  16. Parker LM, Kumar NN, Lonergan T, Burke P, Tallapragada VJ, Damanhuri H, Bowman B, Hassan S, Fletcher S, Goodchild AK. “Subpopulations of Rat Sympathetic Preganglionic Neurons Which Project to Adrenal Chromaffin Cells Are Activated After Glucoprivation”. International Society for Autonomic Neuroscience, Buzios, Brazil. September 2011.
  17. Parker LM. “Short and Sweet! Do Sympathetic Preganglionic Neurons that Respond to Glucoprivation Have a Neurochemical Code?” ASAM data club, Sydney, Australia, February 2012.
  18. Parker LM. “Cracking the Neurochemical Code”. ASAM 3 minute thesis competition, Sydney, Australia, August 2012.
  19. Wearne TA, Parker LM, Goodchild AK, and Cornish JL. “GABAergic mRNA Expression is Differentially Expressed in Subregions of the Prefrontal Cortex of Rats Sensitised to Methamphetamine”. Psychology Postgraduate Conference, Sydney, Australia. 2012.
  20. Parker LM, Kumar NN, Damanhuri H, Tallapragada VJ, Fletcher S, Goodchild AK. “The Neurochemistry of Neurons in the Brainstem and Spinal Cord Which Respond to Stressors”. Macquarie University ASAM completion seminar, Sydney, Australia. March 2013.
  21. Parker LM, H Damanhuri, S Fletcher, AK Goodchild. “The sympathoadrenal pathway activated by hydralazine induced hypotension: activation of sympathetic preganglionic neurons which mobilize glucose”. International Society for Autonomic Neuroscience Meeting, Giessen, Germany, July 2013.
  22. Goodchild, AK, Parker, LM, Bokiniec, P, Haynes, PA, Mirzaei, M. “Proteomic changes in the RVLM of SHR compared to WKY.” Central Cardiovascular and Respiratory Control: Future Directions, Melbourne, Australia. September 2014.
  23. Parker LM, Hardwick, K, Wearne, TA, Goodchild, AK. “Neurochemical code of ventrolateral medulla neurons that regulate homeostatic blood pressure or blood glucose responses.” Central Cardiovascular and Respiratory Control: Future Directions, Melbourne, Australia. September 2014.
  24. Parker LM. “The visualisation of novel and established fluorescently conjugated particles in vitro and in vivo.” Macquarie Node CNBP Seminar (Invited Talk). Sydney, Australia. May 2015.
  25. Ann K Goodchild, Phillip Bokiniec, Sarah F Hassan, Paul Haynes, Lindsay M Parker, Roshana Vander Wall, M Moghaddam, Mehdi Mirzaei. “Molecular changes in the adrenal medulla and brain following glucoprivation”. International Society for Autonomic Neuroscience Meeting, Stresa, Italy September 2015
  26. Parker LM. “Advanced in situ hybridisation techniques: FISH, LISH, DISH and SuperFISH.” CNBP Annual Retreat (Invited Talk). Lake Macquarie, Australia. November 2015.
  27. Parker LM, Staikopoulos V, Cordina N, Sayyadi N, Hutchinson MR, Packer NH. “Fluorescent nanodiamond and lanthanide labelled in situ hybridization for the identification of RNA transcripts in fixed cells and spinal cord tissues.” SPIE Neurophotonics. San Francisco, California, USA. February 2016.
  28. Parker LM. “New tools for measuring mRNA levels in cells and spinal cord tissues.” University of Colorado Boulder (Invited Talk). Boulder, Colorado, USA. February 2016.
  29. Parker LM. “Illuminating mRNA and proteins in new ways with nanoparticles and chemical conjugates.” Macquarie Node CNBP Seminar (Invited Talk). Sydney, Australia. April 2016.
  30. Lindsay M Parker, Nicole M Cordina, Emma R. Wilson, Minakshi Das, Philipp Reineck, Arthur Chien, Chao Shen, Brant Gibson, Nicolle H. Packer. Applications for bio-conjugated nanodiamonds in neuroimaging. ICONN 2018 – International Conference on Nanoscience and Nanotechnology, 29 Jan -2 Feb 2018, University of Wollongong, Australia.
  31. Lindsay M Parker, Arun Everest-Dass, Nicole M Cordina, Sameera Iqbal, Christopher Ashwood, Philipp Reineck, Mina Ghanimi-Fard, Nicolle H. Packer. Targeting the cellular glycan surface for nanoparticle based uptake and imaging in the central nervous system. HUPO Brain Protein Project 2018 Workshop May 8-9, Adelaide, Australia.

Conference Abstracts

Career total = 50+ Conference Abstracts including 15+ Published Abstracts

Published Conference Abstracts:

  1. Esfahanian M, Wehrwein EA, Parker LM,Wright AA, Mastenbrook JD, Novotny M, Mocko V, Swain GM, Kreulen DL. 6-Hydroxydopamine treatment depletes norepinephrine but does not reduce other markers of sympathetic neurons in the heart. FASEB Journal 21 (6), A1264-A1264, May 2007.
  2. Wehrwein EA, Parker LM, Esfahanian M, Cao X, Gariepy C, Watts SW, and Kreulen DL. ETB receptor deficient rats have an elevation of ETB receptor and norepinephrine transporter protein in stellate ganglia. FASEB Journal 21 (6), A1264-A1264, May 2007.
  3. Parker LM, Wehrwein EA, Esfahanian M, Fink GD, and Kreulen DL. Norepinephrine transporter mRNA and protein are increased in left stellate from deoxycorticosterone-acetate (DOCA)-salt hypertensive rats. FASEB Journal 21 (6), A893-A893, May 2007.
  4. Parker LM, Li M, Esfahanian M, Fink GD, Kreulen DL. Evaluation of the cardiovascular actions of sympathetic ganglion endothelin B receptors. FASEB Journal 22, April 2008.
  5. Parker LM and Goodchild AK.Distribution of G alpha subunit mRNA in rat adrenal cortex and adrenal medulla.FASEB Journal 24, April 2010.
  6. Kumar NN, Allen K, Damanhuri H, Parker LM, Goodchild AK. Neuropeptide coding of adrenally projecting sympathetic preganglionic neurons. Hypertension. 55 (6), 1499-1499, June 2010.
  7. Parker LM, Kumar NN, Lonergan T, Goodchild AK. Subpopulations of rat sympathetic preganglionic neurons which project to adrenal chromaffin cells are activated after glucoprivation. Autonomic Neuroscience 163 (1), 69-70, September 2011.
  8. Kreulen DL, Novotny M, Babankova D, Swain GM, Habecker BA, Wehrwein EA, Parker LM Wright AA, Spitsbergen JM. Cardiac norepinephrine transporter protein expression. Cardiovasc Res., August 2010.
  9. Goodchild AK, Parker LM, Damanhuri HA, Fletcher S. Neurochemistry of the sympathoadrenal pathway activated by hydralazine induced hypotension. Autonomic Neuroscience 177 (1), 43-44, July 2013.
  10. Wearne TA, Parker LM, Franklin JF, Goodchild AK, and Cornish JL. Methamphetamine-induced behavioural sensitization is associated with global changes to the GABAergic profile of the rat prefrontal cortex. Behavioural Pharmacology, September 2013.
  11. Wearne TA, Parker LM, Franklin JF, Goodchild AK, and Cornish JL. GABAergic mRNA expression is differentially expressed in subregions of the prefrontal cortex of rats sensitised to methamphetamine. European Neuropsychopharmacology 23, S425-S426, October 2013.
  12. Ann K Goodchild, Phillip Bokiniec, Sarah F Hassan, Paul Haynes, Lindsay M Parker, Roshana Vander Wall, M Moghaddam, Mehdi Mirzaei. Molecular changes in the adrenal medulla and brain following glucoprivation. Autonomic Neuroscience. DOI: 10.1016/j.autneu.2015.07.394. September 2015.
  13. A Goodchild, P Bokiniec, RV Wall, S Hassan, L Parker, M Moghaddam. Proteomic changes in the adrenal medulla following a single episode of glucoprivation: a time-course study. Journal of Neurochemistry 134, 231-231 August 2015.
  14. S. J. Baracz, L. M. Parker, A. S. Suraev, N. A. Everett, A. K. Goodchild, I. S. McGregor and J. L. Cornish. Chronic Methamphetamine Self-Administration Dysregulates Oxytocin Plasma Levels and Oxytocin Receptor Fibre Density in the Nucleus Accumbens Core and Subthalamic Nucleus of the Rat. Journal of NeuroendocrinologyVolume 28, Issue 4, April 2016. DOI: 10.1111/jne.12337
  15. Parker LM, Staikopoulos V, N Cordina NM, Sayyadi N, Hutchinson MR, Packer NH (2016). Fluorescent nanodiamond and lanthanide labelled in situ hybridization for the identification of RNA transcripts in fixed and CLARITY-cleared central nervous system tissues. SPIE BiOS, 969017-969017-1, Photonics West Conference, February 2016. San Francisco, California, USA.

Conference Abstracts:

    1. Parker LM, Wehrwein EA, Esfahanian M, Fink GD, and Kreulen DL. Norepinephrine transporter mRNA and protein are increased in left stellate from deoxycorticosterone-acetate (DOCA)-salt hypertensive rats. Experimental Biology, Washington DC, May 2007.
    2. Wehrwein EA, Parker LM, Esfahanian M, Cao X, Gariepy C, Watts SW, and Kreulen DL. ETB receptor deficient rats have an elevation of ETB receptor and norepinephrine transporter protein in stellate ganglia. Experimental Biology, Washington DC, May 2007.
    3. Esfahanian M, Wehrwein EA, Parker LM,  Wright AA, Mastenbrook JD, Novotny M, Mocko V, Swain GM, Kreulen DL. 6-Hydroxydopamine treatment depletes norepinephrine but does not reduce other markers of sympathetic neurons in the heart. Experimental Biology, Washington DC, May 2007.
    4. Parker LM, Wehrwein EA, Esfahanian M, Fink GD, and Kreulen DL. Norepinephrine transporter mRNA and protein are increased in left stellate from deoxycorticosterone-acetate (DOCA)-salt hypertensive rats. Michigan Society For Neuroscience, Ann Arbor, Michigan, May 2007.
    5. Wehrwein EA, Parker LM, Esfahanian M, and Kreulen DL. Stellate Ganglionic Norepinephrine Transporter (NET) mRNA from Hypertensive Rats is Unchanged while NET Protein is Increased in Left Stellate Ganglia. FASEB (Neural Mechanisms in Cardiovascular Regulation) Conference Sydney, Australia, July 2007.
    6. Parker LM, Esfahanian M, Wehrwein EA, Cao X, Affonso CL, Wang X, and Kreulen DL. Salt-sensitive Hypertension That Develops in Rescued ETB Receptor Deficient Rats is Not Due to Overexpression of ETB receptor mRNA in Sympathetic Ganglia. Regional Hypertension Conference, Gull Lake, Michigan, September 2007.
    7. Parker LM, Li M, Esfahanian M, Fink GD, Kreulen DL. Evaluation of the cardiovascular actions of sympathetic ganglion endothelin B receptors. Experimental Biology, San Diego, California, April 2008.
    8. Parker LM, Li M, Esfahanian M, Fink GD, Kreulen DL. Evaluation of the cardiovascular actions of sympathetic ganglion endothelin B receptors. Michigan Society for Neuroscience, Detroit, Michigan, May 2008.
    9. Kreulen DL, Parker LM, Li M, Esfahanian M, Henley CL, Fink GD. Cardiovascular Actions of Endothelin B Receptors in sympathetic ganglia. ET11, Montreal, Canada, September 2009.
    10. Kumar NN, Allen K, Parker LM, Goodchild AK. Neuropeptide coding of adrenally projecting sympathetic preganglionic neurons. International Society for Autonomic Neuroscience, Sydney, Australia, September 2009.
    11. Goodchild AK, Tallapragada VJ, Kumar NN, Hildreth C, Parker LM, Damanhuri H, Bowman BR, Hassan SF, Allen K. Role cAMP signaling pathways play in the RVLM in modulating sympathetic nerve activity, blood pressure and baroreflex function. Australian Neuroscience Society Meeting, Sydney, Australia, January 2010.
    12. Parker LM and Goodchild AK.Distribution of G alpha subunit mRNA in rat adrenal cortex and adrenal medulla. Experimental Biology Conference, Anaheim, California, April 2010.
    13. Parker LM, Kumar NN, Goodchild AK. G-alpha subunit and phospholipase C beta distribution in the adrenal gland. Central Cardiovascular Control: Future Directions Conference, Sydney, Australia, October 2010.
    14. Kumar NN, Parker LM, DamanhuriH, Goodchild AK. Neurochemistry of functionally specific subpopulations of sympathetic preganglionic neurons projecting to the adrenal gland. Central Cardiovascular Control: Future Directions Conference, Sydney, Australia, October 2010.
    15. Parker LM, Kumar NN, Lonergan T and Goodchild AK. Subpopulations of sympathetic preganglionic neurons and adrenal chromaffin cells are activated after glucoprivation. Australian Neuroscience Society Meeting, Auckland, New Zealand, January-February 2011.
    16. Kumar NN, Lonergan T, Parker LM and Goodchild AK.Induction of Fos immunoreactivity in bulbospinal and neurochemically characterized brain sites during glucoprivation. Australian Neuroscience Society Meeting, Auckland, New Zealand, January-February 2011.
    17. Parker LM, Kumar NN, Lonergan T, Goodchild AK. Subpopulations of rat sympathetic preganglionic neurons which project to adrenal chromaffin cells are activated after glucoprivation. International Society for Autonomic Neuroscience Meeting, Buzios, Brazil, September 2011.
    18. Wearne TA, Parker LM, Franklin JL, Goodchild AK, Cornish JL. GABAergic mRNA expression is differentially regulated in subregoins of the prefrontal cortex in rats sensitized to methamphetamine. Australian Neuroscience Society Meeting, Melbourne, Australia, February 2013.
    19. Parker LM, H Damanhuri, S Fletcher, AK Goodchild. The sympathoadrenal pathway activated by hydralazine induced hypotension: activation of sympathetic preganglionic neurons which mobilize glucose. International Society for Autonomic Neuroscience Meeting, Giessen, Germany, July 2013.
    20. Wearne TA, Parker LM, Franklin JF, Goodchild AK, and Cornish JL. Methamphetamine-induced behavioural sensitization is associated with global changes to the GABAergic profile of the rat prefrontal cortex. European Behavioural Pharmacology Society Bienniel Meeting, La Rochelle, France, September 2013.
    21. Wearne TA, Parker LM, Franklin JF, Goodchild, AK, and Cornish, JL. GABAergic mRNA expression is differentially expressed in subregions of the prefrontal cortex of rats sensitised to methamphetamine. European College of Neuropsychopharmacology Congress, Barcelona, Spain, October 2013.
    22. Mirzaei M, Moghaddam MZ, Parker LM, Bokiniec P, Wu Y, Haynes P, Goodchild AK. Quantitative proteomic analysis of rat adrenal medulla in response to 2-deoxy-D-glucose. American Society for Mass Spectrometry Annual Conference, Baltimore, USA June 2014.
    23. Goodchild AK, Tallapragada VJ, Parker LM, Kumar NN, Burke P GR, McMullan S, Haynes PA and Mirzaei M. Functional and proteomic changes which underlie differences in neuronal function in the rostral ventrolateral medulla (RVLM) of Spontaneously Hypertensive rats (SHR) compared to normotensive rats. Physiology 2014, London, UK, June-July 2014.
    24. A Goodchild, P Bokiniec, RV Wall, S Hassan, L Parker, M Moghaddam. Proteomic changes in the adrenal medulla following a single episode of glucoprivation: a time-course study. Meeting of the International Society for Neurochemistry, Cairns, Australia. August 2015.
    25. S. J. Baracz, L. M. Parker, A. S. Suraev, N. A. Everett, A. K. Goodchild, I. S. McGregor and J. L. Cornish. Chronic Methamphetamine Self-Administration Dysregulates Oxytocin Plasma Levels and Oxytocin Receptor Fibre Density in the Nucleus Accumbens Core and Subthalamic Nucleus of the Rat. 11th World Congress on Neurohypophysial Hormones, Queenstown, New Zealand, August–September 2015.
    26. Parker LM, Cordina N, Sayyadi N, Lu J, Lu Y, Liang O, Care A, Staikopoulos V, Jin D, Hutchinson MR, Packer N. Advanced in situ hybridisation for cellular mRNA detection: FISH, DISH, LISH and SuperFISH. Macquarie Biofocus Conference, Sydney, Australia December 2015.
    27. Nicole M. Cordina, Lindsay M. Parker, Louise J. Brown and Nicolle H. Packer (2015). Fluorescent nanodiamonds for specific cellular targeting: preparation and application. 5th Annual Macquarie Biofocus Research Conference, December 2015. Sydney, Australia.
    28. +Minakshi Das, Lindsay Parker, Yiqing Lu, Lianmei Jiang, Nima Sayyadi, Xiaoxue Xu and Nicolle Packer (2016). A Nanocomplex of Upconversion Nanoparticles and Cholera Toxin B For Use In Neuronal Tracing. 5th Annual Macquarie Biofocus Research Conference, December 2015. Sydney, Australia.
    29. Parker LM, Staikopoulos V, N Cordina NM, Sayyadi N, Hutchinson MR, Packer NH (2016). Fluorescent nanodiamond and lanthanide labelled in situ hybridization for the identification of RNA transcripts in fixed and CLARITY-cleared central nervous system tissues. SPIE BiOS, 969017-969017-1, Photonics West Conference, February 2016. San Francisco, California, USA.
    30. +Parker LM, Staikopoulos V, Cordina N, Sayyadi N, Lu J, Lu Y, Liang O, Care A, Jin D, Hutchinson MR, Packer NH (2016). Illuminating mRNA and proteins in new ways with nanoparticles and chemical conjugates. ANFF/AFOSR Enabling Technologies Technical Exchange Meeting, May 2016. UNSW, Sydney Australia.
    31. +Parker LM, Cordina NM, Sayyadi N, Staikopoulos V, Care A, Reineck P, Lu J, Lu Y, Liang O, Jin D, Hutchinson MR, Piper J, Packer NH (2016). Illuminating neuronal mRNA and proteins with photostable nanoparticles and long-lifetime chemical conjugates. 18th Meeting of the International Society for Comparative Psychology, July 2016. University of Sydney, Australia.
    32. Parker LM, Cordina NM, Das M, Xu X, Lu Y, Packer NH (2016). Nanoparticle based cholera toxin B labelling for photostable neuronal tracing. Inter-University Neuroscience and Mental Health Conference, September 2016. Sydney, Australia.
    33. +Reineck P, Francis A, Orth A, Lau DWM, Nixon-Luke RDV, Rastogi ID, Razali WAW, Cordina NM, Parker LM, Sreenivasan VKA, Brown LJ, Gibson BC (2016). Brightness and photostability of emerging red and near-IR fluorescent nanomaterials for bioimaging. SPIE Biophotonics Australasia, October 2016. Adelaide, Australia.
    34. +Parker LM, Cordina NM, Sayyadi N, Staikopoulos V, Care A, Reineck P, Lu J, Lu Y, Liang O, Jin D, Hutchinson MR, Piper J, Packer NH (2016). Novel ways to illuminate cells and biological tissues using nanoparticles and chemical conjugates. SPIE Biophotonics Australasia, October 2016. Adelaide, Australia.
    35. Denitza Denkova, Martin Ploschner, Lindsay Parker, Alfonso Garcia-Bennett, Yiqing Lu, Nicolle Packer, and James A. Piper (2016). Nanoscale imaging of solid state bio-markers for sensing applications. Emerging Sensing Technologies Summit,December 2016. Melbourne, Australia.
    36. +Denitza Denkova, Varun Sreenivasan, Martin Ploschner, Alf Garcia-Bennett, Lindsay M. Parker, Yiqing Lu, James A. Piper (2017). Nanoscale imaging of solid state particles for bio applications. Photonics West Conference, February 2017. San Francisco, California, USA.
    37. Cordina, L. Parker, A. Dass, Z. Zhao, M. Stoodley, N. Packer (2017). Targeting fluorescent nanodiamonds to E-selectin for the detection of inflammation. Accepted 18 Feb 2017 for poster presentation at the 11th Conference on New Diamond and Nano Carbons, 28 May – 1 June 2017. Cairns Australia.
    38. +Lindsay M Parker, Nicole M Cordina, Philipp Reineck, Minakshi Das, Brant Gibson, Nicolle H. Packer (2017). Applications of fluorescent nanodiamonds in cellular molecular tracing. Accepted 18 Feb 2017 for oral presentation at the 11th Conference on New Diamond and Nano Carbons, 28 May – 1 June 2017. Cairns Australia.
    39. Lindsay M Parker, Minakshi Das, Nicole M Cordina, Philipp Reineck, Xiaoxue Xu, Yiqing Lu, Brant Gibson, Nicolle H. Packer (2017). Novel probes for background-free cellular tracing. Society for Neuroscience 2017 annual meeting 11-15 Nov 2017. Washington DC, USA.
    40. Minakshi Das, Xiaoxue Xu, Lindsay M Parker, Nicolle H. Packer (2017). A novel sugar-based ligand exchange strategy to solubilise upconversion nanoparticles. ICONN 2018 - International Conference on Nanoscience and Nanotechnology, 29 Jan -2 Feb 2018, University of Wollongong, Australia.
    41. +Lindsay M Parker, Nicole M Cordina, Emma R. Wilson, Minakshi Das, Philipp Reineck, Arthur Chien, Chao Shen, Brant Gibson, Nicolle H. Packer. Applications for bio-conjugated nanodiamonds in neuroimaging. ICONN 2018 - International Conference on Nanoscience and Nanotechnology, 29 Jan -2 Feb 2018, University of Wollongong, Australia
    42. Emma R. Wilson, L. Parker, P. Reineck, O. Shenderova, N. Nunn, M. Torellia, N.H. Packer and B.C. Gibson (2017). Fluorescent nanodiamonds for in vitro bioimaging: the effect of particle size on imaging contrast and cell stress. ICONN 2018 - International Conference on Nanoscience and Nanotechnology, 29 Jan -2 Feb 2018, University of Wollongong, Australia.
    43. +Lindsay M Parker, Arun Everest-Dass, Nicole M Cordina, Sameera Iqbal, Christopher Ashwood, Philipp Reineck, Mina Ghanimi-Fard, Nicolle H. Packer. Targeting the cellular glycan surface for nanoparticle based uptake and imaging in the central nervous system. HUPO Brain Protein Project 2018 Workshop May 8-9, Adelaide, Australia
    44. Philipp Reineck, Desmond Lau, Lindsay Parker, Emma R. Wilson, Giannis Thalassinos, Nicholas Nunn, Leevan Trindade, Cholaphan Deeleepojananan, Marco Capelli, 2, Shery Chang, Takeshi Ohshima, David A. Simpson, Andrew D. Greentree, Petr Cigler, Olga Shenderova, Vadym N. Mochalin, Girard Hugues, Jean-Charles Arnault, Brant C. Gibson. Not all nanodiamonds are created equal: the optical properties of nanodiamonds and applications in biology. NDNC. Flagstaff, Arizona, USA May 2018.
    45. Annemarie Nadort, Sameera Iqbal, Lindsay Parker, Nicolle Packer, Ewa Goldys, Anna Guller. Closer to nature in vitro: organ-specific extracellular matrix-based three dimensional models of cancer. ComBio2018, Sydney, Australia September 2018.
    46. Philipp Reineck, Desmond Lau, Lindsay Parker, Emma R. Wilson, Giannis Thalassinos, Nicholas Nunn, Leevan Trindade, Cholaphan Deeleepojananan, Marco Capelli, 2, Shery Chang, Takeshi Ohshima, David A. Simpson, Andrew D. Greentree, Petr Cigler, Olga Shenderova, Vadym N. Mochalin, Girard Hugues, Jean-Charles Arnault, Brant C. Gibson. Fluorescent nanodiamonds: from the creation and characterization of optical defects to applications in biology. Diamond and Carbon Materials Conference, Dubrovnik, Croatia, September 2018.

 

  1. Anna Guller,Annemarie Nadort,Zahra Khabir,Inga Kuschnerus,Sameera Iqbal,Vlada Rozova,Liuen Liang,Lindsay Parker, Alfonco Garcia-Bennett,Nicki Packer,Ewa Goldys,Andrei Zvyagin,Yi Qian. Tissue Engineering Models of Breast Carcinoma and Malignant Glioma for Cancer Biology research, Drug Testing and Diagnostic Tools’ Development. 2018 TERMIS (Tissue Engineering and Regenerative Medicine International Society) World Congress in Kyoto, Japan, 4-7th September 2018.
  2. Dr Denitza Denkova, Dr Martin Ploschner, Ms Minakshi Das, Dr Lindsay Parker, Dr Xianlin Zheng, Dr Yiqing Lu, Prof Nicki Packer, Prof Jim Piper. Sub-diffraction imaging using upconversion nanoparticles. Optics Within Life Sciences (OWLS) Perth, Australia, 25 - 28 November 2018.
  3. Philipp Reineck, Desmond Lau, Emma R. Wilson, Giannis Thalassinos, Kate Fox, Nicholas Nunn, Marco Torelli, Leevan Trindade, Cholaphan Deeleepojanana, Marco Capelli, Shery Chang, Lindsay Parker, Takeshi Ohshima, David A. Simpson, Andrew D. Greentree, Petr Cigler, Olga Shenderova, Vadym N. Mochalin, Girard Hugues, Jean-Charles Arnault, Adam Dalis, Patrick Keith Capon, Andrew Abell, Brant C. Gibson. Fluorescent nanodiamonds: from the creation and characterization of optical defects to applications in biology. Australian Institute of Physics Congress. Perth, Australia. December 2018.
  4. J Cornish, J Franklin, A Goodchild, L Parker, Travis Wearne. Gene expression is differentially expressed across the prefrontal cortex following sensitisation to methamphetamine. AUSTRALIAN PSYCHOLOGIST, 2018.
  5. Minakshi Das, Lindsay Parker, Denitza Denkova, Martin Ploschner, Xianlin Zheng, Yiqing Lu, Jim Piper, Nicki Packer. Polysaccharide coated upconversion nanoparticles for uptake and imaging in macrophage cells. SPIE BIOS 2019, San Francisco, California, United States.
  6. Annemarie Nadort, Mahsa Vaez Zadeh, Sameera Iqbal, Mina Ghanimi Fard, Dmitry Polikarpov, Shivani Sachdev, Lindsay Parker, Qian Yi, Andrew Davidson, Nicolle Packer, Ewa Goldys, Anna Guller Engineering 3D living brain tumour equivalents as macroscopic test-systems for the development of optical imaging and sensing applications. SPIE BiOS, 2019, San Francisco, California, United States
  7. Anna Guller, Annemarie Nadort, Zahra Khabir, Inga Kuschnerus, Sameera Iqbal, Vlada Rozova, Liuen Liang, Lindsay Parker, Alfonso Garcia-Bennett, Nicki Packer, Yi Qian, Andrei Zvyagin, Ewa Goldys. ORGAN-SPECIFIC TISSUE ENGINEERING CONSTRUCTS AS PRE-CLINICAL ALTERNATIVE MODELS OF NORMAL AND DISEASED TISSUES FOR EXPERIMENTAL BIOMEDICINE. Biomimetics in Bioengineering /Nature conference. Brisbane, Australia August 2019.

Contributions to Science

Early Career: During my early career I worked with a team of graduate students who were investigating sympathetic ganglia and heart tissues in normal rats with regional sympathetic nerve destruction or rats with DOCA-salt hypertension. In one of our publications we were able to demonstrate in hypertensive rats that a protein producing superoxide is regulated in opposite directions in sympathetic neurons and sensory neurons. In another publication I helped describe the differential regional expression of norepinephrine transporter protein across heart chambers. I additionally conducted my own independent research studying cardiovascular responses in a hypertensive model of rats that overexpress endothelin B receptors selectively in their sympathetic nervous system.

Graduate Career: I produced several first author publications during my graduate career on molecular mechanisms contributing to hypertension and hypoglycemia. My graduate research helped to identify specific neurochemical codes of brainstem and spinal cord neurons that regulate adrenal gland release of adrenaline and noradrenaline in response to lowering blood glucose drastically. I additionally studied the distribution of Gα protein mRNAs in the brainstem and adrenal glands of rats with neurogenic hypertension and found an increase in excitatory Gα subunit mRNA in these regions suggesting increased excitatory neuropeptide signaling in blood pressure regulating neurons.

Postdoctoral Career: In my post-doctoral career I have discovered that spinal cord neurons regulating blood glucose or blood pressure have district neurochemical codes. I have contributed to publications describing protein changes during neuronal differentiation and in ground state pluripotency. I have also trained graduate students and assisted them in analyzing molecular changes in the rat prefrontal cortex, nucleus accumbens and subthalamic nucleus following self-administered methamphetamines.  I have developed new ISH techniques using nanodiamonds and europium lanthanide conjugates. Currently I am working on developing nanobiotechnology based tools for targeting sugar receptors on the surface of brain cells in chronic pain and brain cancer.